Regulation of Functionally Active P2Y12 ADP Receptors by Thrombin in Human Smooth Muscle Cells and the Presence of P2Y12 in Carotid Artery Lesions
Author(s) -
Bernhard Rauch,
A Rosenkranz,
Swen Ermler,
Andreas Böhm,
Julia Driessen,
Jens W. Fischer,
Atsuhiro Sugidachi,
Joseph A. Jakubowski,
Karsten Schrör
Publication year - 2010
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.110.213702
Subject(s) - p2y12 , thienopyridine , thrombin , tissue factor , prasugrel , platelet , receptor , medicine , gene knockdown , chemistry , microbiology and biotechnology , endocrinology , biology , clopidogrel , biochemistry , aspirin , coagulation , apoptosis , platelet aggregation
The platelet P2Y12 ADP receptor is a well-known target of thienopyridine-type antiplatelet drugs. This study is the first to describe increased transcriptional expression of a functionally active P2Y12 in response to thrombin in human vascular smooth muscle cells (SMC).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom